Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 75 Carcinoma, Hepatocellular 47 Ovarian Neoplasms 40 Carcinoma, Non-Small-Cell Lung 26 Neoplasms 22 Fallopian Tube Neoplasms 17 Lung Neoplasms 15 Breast Neoplasms 13 Neoplasm Metastasis 12 Glioblastoma 12 Endometrial Neoplasms 12 Brain Neoplasms 12 Colonic Neoplasms 11 Triple Negative Breast Neoplasms 10 Rectal Neoplasms 10 Uterine Cervical Neoplasms 9 Liver Neoplasms 9 Stomach Neoplasms 8 Colorectal Cancer Metastatic 7 Pancreatic Neoplasms 6 Advanced Solid Tumors 6 Recurrence 5 Melanoma 5 Glioma 5 Carcinoma, Renal Cell 5 Carcinoma, Ovarian Epithelial 5 Biliary Tract Neoplasms 5 Solid Tumor 4 Meningeal Carcinomatosis 4 Adenocarcinoma of Lung 4

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Advanced Liver Cancers × Bevacizumab × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡